MNKD Q1 2017 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$841M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M

Gross Profit

$461,00015.3% margin

Operating Income

-$20M-651.4% margin

Net Income

-$16M-542.5% margin

EPS (Diluted)

$-0.17

QoQ Revenue Growth

-75.7%

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

$9M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$85M

Total Liabilities

$284M

Stockholders' Equity

-$199M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$0	—
Gross Profit	$461,000	-$5M	+108.9%
Operating Income	-$20M	-$20M	+2.1%
Net Income	-$16M	-$25M	+34.4%